Participation of central and peripheral opioid receptors in mechanisms of arrhythmogenesis

Yu B. Lishmanov, L. N. Maslov

Результат исследований: Материалы для журналаСтатья

Выдержка

This study was designed to determine the role of opioid receptors (OR) in arrhythmogenesis in the models of epinephrine-, aconitine- and CaCl2-induced arrhythmias in rats. The OR ligands were injected icv at a dose of 20 nmol/rat or intravenously (iv) 30 min before the induction of arrhythmias. Mu-OR agonists (DAGO, DALDA) had antiarrhythmic effects with systemic and icv administration. Kappa-OR agonists (spiradoline, U-504488) exhibited antiarrhythmic properties only with iv administration, but icv infusion produced proarrhythmic effects. Ligands of central delta-ORs (DTLET, DSLET, DPDPE, DADLE) increased cardiac resistance to arrhythmogenic influences, but iv administration delta-OR agonists did not affect arrhythmias. The proarrhythmic effects of central administration of kappa-OR agonists were associated with the activation of sympathetic nervous system and were completely eliminated by hexomethonium (10 mg/kg, iv). Antiarrhythmic effects of mu-OR agonists injected icv were completely eliminated by atropine (iv and icv). The mechanisms of increased cardiac resistance to arrythmogenic agents after peripheral mu-OR activation appear to be unclear.

Язык оригиналаАнглийский
ЖурналFASEB Journal
Том11
Номер выпуска3
СостояниеОпубликовано - 1997

Отпечаток

mu Opioid Receptor
narcotics
Opioid Receptors
Cardiac Arrhythmias
kappa Opioid Receptor
enkephalin, Ser(2), Leu(5), Thr(6)-
receptors
agonists
Leucine-2-Alanine Enkephalin
Aconitine
D-Penicillamine (2,5)-Enkephalin
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Ligands
Rats
arrhythmia
delta Opioid Receptor
Chemical activation
Sympathetic Nervous System
Atropine
Epinephrine

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Цитировать

Participation of central and peripheral opioid receptors in mechanisms of arrhythmogenesis. / Lishmanov, Yu B.; Maslov, L. N.

В: FASEB Journal, Том 11, № 3, 1997.

Результат исследований: Материалы для журналаСтатья

@article{e12329f3805a4f07b23868d707205556,
title = "Participation of central and peripheral opioid receptors in mechanisms of arrhythmogenesis",
abstract = "This study was designed to determine the role of opioid receptors (OR) in arrhythmogenesis in the models of epinephrine-, aconitine- and CaCl2-induced arrhythmias in rats. The OR ligands were injected icv at a dose of 20 nmol/rat or intravenously (iv) 30 min before the induction of arrhythmias. Mu-OR agonists (DAGO, DALDA) had antiarrhythmic effects with systemic and icv administration. Kappa-OR agonists (spiradoline, U-504488) exhibited antiarrhythmic properties only with iv administration, but icv infusion produced proarrhythmic effects. Ligands of central delta-ORs (DTLET, DSLET, DPDPE, DADLE) increased cardiac resistance to arrhythmogenic influences, but iv administration delta-OR agonists did not affect arrhythmias. The proarrhythmic effects of central administration of kappa-OR agonists were associated with the activation of sympathetic nervous system and were completely eliminated by hexomethonium (10 mg/kg, iv). Antiarrhythmic effects of mu-OR agonists injected icv were completely eliminated by atropine (iv and icv). The mechanisms of increased cardiac resistance to arrythmogenic agents after peripheral mu-OR activation appear to be unclear.",
author = "Lishmanov, {Yu B.} and Maslov, {L. N.}",
year = "1997",
language = "English",
volume = "11",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Participation of central and peripheral opioid receptors in mechanisms of arrhythmogenesis

AU - Lishmanov, Yu B.

AU - Maslov, L. N.

PY - 1997

Y1 - 1997

N2 - This study was designed to determine the role of opioid receptors (OR) in arrhythmogenesis in the models of epinephrine-, aconitine- and CaCl2-induced arrhythmias in rats. The OR ligands were injected icv at a dose of 20 nmol/rat or intravenously (iv) 30 min before the induction of arrhythmias. Mu-OR agonists (DAGO, DALDA) had antiarrhythmic effects with systemic and icv administration. Kappa-OR agonists (spiradoline, U-504488) exhibited antiarrhythmic properties only with iv administration, but icv infusion produced proarrhythmic effects. Ligands of central delta-ORs (DTLET, DSLET, DPDPE, DADLE) increased cardiac resistance to arrhythmogenic influences, but iv administration delta-OR agonists did not affect arrhythmias. The proarrhythmic effects of central administration of kappa-OR agonists were associated with the activation of sympathetic nervous system and were completely eliminated by hexomethonium (10 mg/kg, iv). Antiarrhythmic effects of mu-OR agonists injected icv were completely eliminated by atropine (iv and icv). The mechanisms of increased cardiac resistance to arrythmogenic agents after peripheral mu-OR activation appear to be unclear.

AB - This study was designed to determine the role of opioid receptors (OR) in arrhythmogenesis in the models of epinephrine-, aconitine- and CaCl2-induced arrhythmias in rats. The OR ligands were injected icv at a dose of 20 nmol/rat or intravenously (iv) 30 min before the induction of arrhythmias. Mu-OR agonists (DAGO, DALDA) had antiarrhythmic effects with systemic and icv administration. Kappa-OR agonists (spiradoline, U-504488) exhibited antiarrhythmic properties only with iv administration, but icv infusion produced proarrhythmic effects. Ligands of central delta-ORs (DTLET, DSLET, DPDPE, DADLE) increased cardiac resistance to arrhythmogenic influences, but iv administration delta-OR agonists did not affect arrhythmias. The proarrhythmic effects of central administration of kappa-OR agonists were associated with the activation of sympathetic nervous system and were completely eliminated by hexomethonium (10 mg/kg, iv). Antiarrhythmic effects of mu-OR agonists injected icv were completely eliminated by atropine (iv and icv). The mechanisms of increased cardiac resistance to arrythmogenic agents after peripheral mu-OR activation appear to be unclear.

UR - http://www.scopus.com/inward/record.url?scp=33750265932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750265932&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750265932

VL - 11

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -